MORE PRECISE: MULTIOMIC DATA X PATIENT HISTORY
This team understood that genomic testing alone provides only a partial picture of the patient and their cancer, and that advances in technology provided a unique opportunity to analyze multi-modal data for actionable intelligence. For each patient, they would step beyond routine testing and consider the entire range of multiomic molecular data, as well as their personal cancer history.
USING THE POWER OF AI TO TURN COMPLEXITY INTO ACTION
The Perthera Therapeutic Intelligence Engine® has been developed for over a decade, and is driven by proprietary, patented, AI-powered technology.
With 10 Databases that include over 50,000 heuristic rules and algorithms, it factors patient medical history, treatment history, and multiomic molecular information to match patients to therapy options best tailored to their cancer profiles.
Constantly updated and enhanced with new data, and RWE from outcomes analysis, the engine includes published clinical research, active clinical trials, as well as all FDA-approved therapy options.
THE PERTHERA PLATFORM
We built the Perthera Precision Medicine ™ Platform to bring our precision oncology capabilities to oncologists in every care setting, and to make valuable data available for research and the development of new therapies. The Perthera Platform produces the Perthera Report®, and provides access to an expanding pipeline of Real World Evidence.
MAKING PRECISION ONCOLOGY THE STANDARD OF CARE, ACCELERATING INNOVATION
The ongoing evolution of our technology, platform and products will help to power an evolution in clinical and therapeutic oncology so that patients will see better outcomes.
We are determined to make the Perthera Precision Oncology Platform the best available decision-support system for Oncologists, and to make our data pipeline products the leading accelerant for therapeutic innovation.